Dyrla , W. (2012). Rosuvastatin – the impact on the course of atherosclerosis in clinical trials. Medycyna Faktow (J EBM), 5(2(15), 53-57. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2466